With more than 1,000 international actors from 35+ countries, such as big pharma, emerging and small biotech, diagnostic companies, pre-seed / seed / Series A investors, as well as professionals from tech transfer, academia and research institutions, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovation deals in the field of Life Sciences. BioFIT is also the European marketplace for pre-seed, seed and Series A investment rounds in Life Sciences.

This year, the event will be held in a hybrid format on 3–4 December and 11–12 December.

The next Health Talks event brings together leading experts and innovators to explore how cutting-edge technologies such as supercomputing and quantum computing are transforming the drug discovery landscape. 

Read more and register here.